Table 2.
Laboratory findings, history of admission, and follow-up time as clinical variables in the patient study
| Variables | Mean ± SD | ||
|---|---|---|---|
| Age in years Mean, (Range) | 6.98±4.44, (1.2-17 y) | ||
| ALL (%) | B cell | 113 (85%) | High risk: 44 (33%) |
| Standard risk: 69 (52%) | |||
| T cell | 20 (15%) | ||
| Follow-up time in a month Mean, (Range) | 24.71±9.35, (2-72 Mo) | ||
| Karyotype and Cytogenetic abnormality | No | 93 (69.9%) | |
| Yes | 40 (30.1%); | ||
| • Favorable (n=20) | |||
| • Unfavorable (n=17) | |||
| • No prognostic significance (n=3) | |||
| History of Admission due to complications | Yes | 79 (59.4%) | |
| No | 54 (40.6%) | ||
| Hemoglobin | 9.8±1.7 g/dl | ||
| Mean corpuscular volume (MCV) | 83.5±7 fl | ||
| White Blood Cell (WBC) | 5672.4±10651.8/µl | ||
| Red Blood Cell (RBC) | 3.8×106±0.7×106/µl | ||
| Platelet | 150135.1±144338.5/µl | ||
| Lactate dehydrogenase (LDH) | 953±1038 U/L | ||
| Total Bilirubin | 2.5±1.41 mg/dL | ||